Female Genital Diseases Completed Phase 2 / 3 Trials for Octocrylene (DB09535)

IndicationStatusPhase
DBCOND0040170 (Female Genital Diseases)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs